Latest filing published 13 Feb 2026 for Embecta Corp..
On February 26, 2019, Carrie L. Anderson filed at DOVER Corp sales of EUR 657,952 and EUR 73,104, EUR 731,056 in all. They are the only market trades in the record, which holds no purchase.
Anderson holds financial roles at four Nasdaq companies: Executive Vice President & CFO of Integra Lifesciences Holdings Corp (16 filings) and CAMPBELL'S Co (11), Vice President and Controller of DOVER Corp (14), and Director of Embecta Corp. (5). The record holds 46 filings from February 13, 2018 to February 13, 2026, 44 of them grants. They are published a median of 3 days after the trade.
The high is 11 filings in 2022, ahead of 9 in 2019. Volume falls to 2 in 2020, 3 in 2021, 4 in 2024 and 2025, then 1 in 2026. One filing falls within the last twelve months, neither a purchase nor a sale.
Both 2019 sales fall within 30 days of a trade by Anthony K. Kosinski, Ivonne M. Cabrera, Jay L. Kloosterboer and William Spurgeon, in the same direction, all at DOVER Corp.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 46 declarations